home / stock / wint / wint news

WINT News and Press, Windtree Therapeutics Inc. From 04/17/23

Stock Information
Company Name: Windtree Therapeutics Inc.
Stock Symbol: WINT
Market: OTC
Website: windtreetx.com
Menu
WINT WINT Quote WINT Short WINT News WINT Articles WINT Message Board
Get WINT Alerts

News, Short Squeeze, Breakout and More Instantly...
WINT - CNSP and ALVO among healthcare movers

2023-04-17 10:02:16 ET Gainers: Prometheus Biosciences ( RXDX ) +69% . CNS Pharmaceuticals ( CNSP ) +53% . Revelation Biosciences ( REVB ) +29% . Windtree Therapeutics ( WINT ) +26% . Kiromic BioPharma ( KRBP ) +22% . Loser...
WINT - Windtree Therapeutics Announces Issuance of New Dual Mechanism SERCA2a Activator Patent

WARRINGTON, Pa., April 17, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that the European Patent ...

WINT - MBIO, ELOX and WINT among mid-day movers

2023-04-05 13:14:41 ET Gainers: Nuburu ( BURU ) +83% . Liminal BioSciences ( LMNL ) +80% . InflaRx ( IFRX ) +75% . 180 Life Sciences ( ATNF ) +38% . Freight Technologies ( FRGT ) +25% . Omega Therapeutics ( OMGA ) +23% ...

WINT - Windtree TherapeuticS GAAP EPS of -$13.01

2023-04-03 07:47:17 ET Windtree TherapeuticS press release ( NASDAQ: WINT ): Q4 GAAP EPS of -$13.01. As of December 31, 2022, the Company reported cash and cash equivalents of $6.2 million, which is expected to be sufficient to fund operations into the second quarter of 20...
WINT - Windtree Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., April 03, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, today reported financial results for the fourth quarter and fiscal year ended Decembe...

WINT - PRQR, FC and WINT among mid-day movers

2023-03-30 12:33:44 ET Gainers: SCYNEXIS ( SCYX ) +54% . Palisade Bio ( PALI ) +36% . Windtree Therapeutics ( WINT ) +39% . Toro ( TORO ) +34% . F45 Training ( FXLV ) +32% . Pyxis Oncology ( PYXS ) +29% . EVgo ( ...

WINT - Windtree Therapeutics regains compliance with Nasdaq

2023-03-13 11:19:52 ET Windtree Therapeutics ( NASDAQ: WINT ) has received a Bid Price Compliance Letter from The Nasdaq informing Windtree that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule. This requirement was met on March 1...
WINT - Windtree Regains Compliance with Nasdaq

WARRINGTON, Pa., March 13, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced it has received a Bid Pri...

WINT - Windtree Finds Cardiogenic Shock Has High Cost of US Patient Care and Plans Innovation with the Unique Profile of Istaroxime

US Hospital Claims Data Reveals Cardiogenic Shock Patients Have an Average Hospital Length of Stay of 19.6 Days Making Its Intensive Patient Care Cost Very High WARRINGTON, Pa., March 06, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the ...

WINT - Windtree Announces Publication on its SERCA2a Activator Drug Candidate for Chronic and Acute Heart Failure

WARRINGTON, Pa., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, announced that its preclinical st...
Previous 10 Next 10